{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-02.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "community_acquired_pneumonia",
    "name": "Community Acquired Pneumonia (CAP)",
    "setting": "community",
    "synonyms": [
      "CAP"
    ]
  },
  "diagnostics": {
    "orders": [
      "mrsa_nares",
      "sputum_culture"
    ],
    "timing": null,
    "deescalationRules": [
      {
        "test": "mrsa_nares",
        "result": "negative",
        "action": "stop",
        "target": "vancomycin",
        "evidence": {
          "npv": 0.95
        },
        "trace": {
          "page": 1,
          "sourceText": "Negative MRSA nares swab has a >95% negative predictive value for MRSA PNA.",
          "confidence": null
        }
      },
      {
        "test": "sputum_culture",
        "result": "no_mrsa_or_psa_confirmation",
        "action": "narrow",
        "target": "extended_mrsa_psa_coverage",
        "evidence": null,
        "trace": {
          "page": 1,
          "sourceText": "if no microbiologic confirmation of MRSA or PSA, discontinue extended coverage.",
          "confidence": null
        }
      }
    ]
  },
  "pathways": [
    {
      "id": "default",
      "label": "Community Acquired Pneumonia (CAP)",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": null,
        "immunocompromiseGate": null
      },
      "procedureRecommendations": null,
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if no clinical improvement past the expected duration"
        ]
      },
      "durationDays": {
        "min": 5,
        "max": null,
        "from": "start",
        "notes": "Longer duration may be needed if: Severe CAP, Empyema, Complicated by extra-pulmonary infection.",
        "bandsBySeverity": null
      },
      "stopRules": [
        {
          "condition": "azithromycin_dosed_500mg_daily",
          "action": "Discontinue azithromycin at 3 days regardless of total antibiotic duration"
        }
      ],
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "ceftriaxone",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "azithromycin",
                    "variant": "IV/PO"
                  }
                }
              ],
              "notes": [
                "Use Doxycycline IV/PO if contraindication to azithromycin.",
                "ADD Vancomycin IV if: ICU admission, History of MRSA in the last 12months, Suspected lung abscess, empyema, or septic emboli, Influenza/RSV diagnosis in the last 14d."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Ceftriaxone IV (1st) PLUS Azithromycin IV/PO",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "ampicillin-sulbactam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "azithromycin",
                    "variant": "IV/PO"
                  }
                }
              ],
              "notes": [
                "Preferred if aspiration related empyema or lung abscess suspected.",
                "Use Doxycycline IV/PO if contraindication to azithromycin.",
                "ADD Vancomycin IV if: ICU admission, History of MRSA in the last 12months, Suspected lung abscess, empyema, or septic emboli, Influenza/RSV diagnosis in the last 14d."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Ampicillin-sulbactam IV (1st) (preferred if aspiration related empyema or lung abscess suspected) PLUS Azithromycin IV/PO",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "ceftriaxone",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "azithromycin",
                    "variant": "IV/PO"
                  }
                }
              ],
              "notes": [
                "ADD Metronidazole IV/PO if: Aspiration related empyema or lung abscess suspected.",
                "Use Doxycycline IV/PO if contraindication to azithromycin.",
                "ADD Vancomycin IV if: ICU admission, History of MRSA in the last 12months, Suspected lung abscess, empyema, or septic emboli, Influenza/RSV diagnosis in the last 14d."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Ceftriaxone IV (1st) PLUS Azithromycin IV/PO",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "levofloxacin",
                "variant": "IV/PO"
              },
              "adjuncts": null,
              "notes": [
                "ADD Vancomycin IV if: ICU admission, History of MRSA in the last 12months, Suspected lung abscess, empyema, or septic emboli, Influenza/RSV diagnosis in the last 14d.",
                "ADD Aztreonam IV if: ICU admission.",
                "ADD Metronidazole IV/PO If: Aspiration related empyema or lung abscess suspected."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Levofloxacin IV/PO (1st)",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": []
  }
}
2. Hospital-Acquired / Ventilator-Associated Pneumonia (from abx-03.pdf)
JSON

{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-03.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "hospital_acquired_pneumonia",
    "name": "Hospital-Acquired / Ventilator-Associated Pneumonia",
    "setting": "hospital",
    "synonyms": [
      "HAP",
      "VAP",
      "CAP with MDRO risk factors"
    ]
  },
  "diagnostics": {
    "orders": [
      "mrsa_nares",
      "sputum_culture"
    ],
    "timing": null,
    "deescalationRules": [
      {
        "test": "mrsa_nares",
        "result": "negative",
        "action": "stop",
        "target": "vancomycin",
        "evidence": {
          "npv": 0.95
        },
        "trace": {
          "page": 1,
          "sourceText": "Negative MRSA nares swab has a >95% negative predictive value for MRSA PNA.",
          "confidence": null
        }
      },
      {
        "test": "sputum_culture",
        "result": "no_mrsa_or_psa_confirmation",
        "action": "narrow",
        "target": "extended_mrsa_psa_coverage",
        "evidence": null,
        "trace": {
          "page": 1,
          "sourceText": "if no microbiologic confirmation of MRSA or PSA, discontinue extended coverage.",
          "confidence": null
        }
      }
    ]
  },
  "pathways": [
    {
      "id": "mdro_risk",
      "label": "CAP with risk factors for MDRO, Hospital-Acquired Pneumonia (HAP), or Ventilator-Associated Pneumonia (VAP)",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": [
          "history_pseudomonas_or_mdro_last_year",
          "iv_antibiotic_use_last_90_days",
          "prolonged_mechanical_ventilation_or_tracheostomy",
          "immunocompromised",
          "advanced_structural_lung_disease"
        ],
        "careLocationIn": null,
        "clinicalStateIn": null,
        "immunocompromiseGate": null
      },
      "procedureRecommendations": null,
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if no clinical improvement past the expected duration",
          "if patient has a history of organisms that are resistant to the recommended empiric regimen"
        ]
      },
      "durationDays": {
        "min": 5,
        "max": 7,
        "from": "start",
        "notes": "CAP: 5 days. HAP/VAP: 5-7 days. Ultra short course (≤3 days) can be considered in patients with suspected VAP but minimal and stable ventilator settings (PEEP ≤5 cm H₂O and FiO₂ ≤40%).",
        "bandsBySeverity": null
      },
      "stopRules": [
        {
          "condition": "azithromycin_dosed_500mg_daily",
          "action": "Discontinue azithromycin at 3 days regardless of total antibiotic duration"
        }
      ],
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": [
              "septic_shock"
            ],
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "ADD Azithromycin IV/PO if CAP (Doxycycline IV/PO if contraindication)",
                "ADD vancomycin IV if: HAP/VAP, ICU admission, History of MRSA in the last 12months, Suspected lung abscess, empyema, or septic emboli, Influenza/RSV diagnosis in the last 14d"
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st)",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "piperacillin-tazobactam",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "Preferred in aspiration related empyema or lung abscess suspected",
                "ADD Azithromycin IV/PO if CAP (Doxycycline IV/PO if contraindication)",
                "ADD vancomycin IV if: HAP/VAP, ICU admission, History of MRSA in the last 12months, Suspected lung abscess, empyema, or septic emboli, Influenza/RSV diagnosis in the last 14d"
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Piperacillin-tazobactam IV (1st)",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": {
            "drugRef": {
              "name": "tobramycin",
              "variant": "IV"
            },
            "doseNote": "5mg/kg (IBW) x 1 dose, or 2mg/kg (IBW) if HD or CrCl <20"
          }
        },
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "ADD Azithromycin IV/PO if CAP (Doxycycline IV/PO if contraindication)",
                "ADD vancomycin IV if: HAP/VAP, ICU admission, History of MRSA in the last 12months, Suspected lung abscess, empyema, or septic emboli, Influenza/RSV diagnosis in the last 14d"
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st)",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "piperacillin-tazobactam",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "Preferred in aspiration related empyema or lung abscess suspected",
                "ADD Azithromycin IV/PO if CAP (Doxycycline IV/PO if contraindication)",
                "ADD vancomycin IV if: HAP/VAP, ICU admission, History of MRSA in the last 12months, Suspected lung abscess, empyema, or septic emboli, Influenza/RSV diagnosis in the last 14d"
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Piperacillin-tazobactam IV (1st)",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": [
              "septic_shock"
            ],
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "ADD Metronidazole IV/PO if: Aspiration related empyema or lung abscess suspected",
                "ADD Azithromycin IV/PO if CAP (Doxycycline IV/PO if contraindication)",
                "ADD vancomycin IV if: HAP/VAP, ICU admission, History of MRSA in the last 12months, Suspected lung abscess, empyema, or septic emboli, Influenza/RSV diagnosis in the last 14d"
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st)",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": {
            "drugRef": {
              "name": "tobramycin",
              "variant": "IV"
            },
            "doseNote": "5mg/kg (IBW) x 1 dose, or 2mg/kg (IBW) if HD or CrCl <20"
          }
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "ADD Metronidazole IV/PO if: Aspiration related empyema or lung abscess suspected",
                "ADD Azithromycin IV/PO if CAP (Doxycycline IV/PO if contraindication)",
                "ADD vancomycin IV if: HAP/VAP, ICU admission, History of MRSA in the last 12months, Suspected lung abscess, empyema, or septic emboli, Influenza/RSV diagnosis in the last 14d"
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st)",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": [
              "septic_shock"
            ],
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "levofloxacin",
                "variant": "IV/PO"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "aztreonam",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "ADD vancomycin IV if: HAP/VAP, ICU admission, History of MRSA in the last 12months, Suspected lung abscess, empyema, or septic emboli, Influenza/RSV diagnosis in the last 14d",
                "ADD Metronidazole IV/PO If: Aspiration related empyema or lung abscess suspected"
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Levofloxacin IV/PO (1st) PLUS Aztreonam IV (1st)",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": {
            "drugRef": {
              "name": "tobramycin",
              "variant": "IV"
            },
            "doseNote": "5mg/kg (IBW) x 1 dose, or 2mg/kg (IBW) if HD or CrCl <20"
          }
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "levofloxacin",
                "variant": "IV/PO"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "aztreonam",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "ADD vancomycin IV if: HAP/VAP, ICU admission, History of MRSA in the last 12months, Suspected lung abscess, empyema, or septic emboli, Influenza/RSV diagnosis in the last 14d",
                "ADD Metronidazole IV/PO If: Aspiration related empyema or lung abscess suspected"
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Levofloxacin IV/PO (1st) PLUS Aztreonam IV (1st)",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": []
  }
}
3. Cystitis (from abx-04.pdf)
JSON

{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-04.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "cystitis",
    "name": "Cystitis",
    "setting": "community",
    "synonyms": [
      "uncomplicated UTI"
    ]
  },
  "diagnostics": {
    "orders": [
      "urinalysis",
      "urine_culture"
    ],
    "timing": [
      {
        "test": "urinalysis_and_culture",
        "preAntibioticPreferred": true
      }
    ],
    "deescalationRules": null
  },
  "pathways": [
    {
      "id": "default",
      "label": "Cystitis with urinary symptoms only (no fever or other systemic signs)",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": null,
        "immunocompromiseGate": null
      },
      "procedureRecommendations": null,
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if no clinical improvement past the expected duration",
          "if alternative regimen needed"
        ]
      },
      "durationDays": {
        "min": 1,
        "max": 7,
        "from": "start",
        "notes": "Nitrofurantoin: 5 days. TMP/SMX: 3 days. Fosfomycin: 1 day. Cefazolin: 3-5 days. Cephalexin/Cefpodoxime: 5-7 days. In patients with functional or structural GU abnormalities, 7 days of therapy is sufficient in most cases.",
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none",
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "nitrofurantoin",
                "variant": "PO"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Nitrofurantoin PO",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "fosfomycin",
                "variant": "PO"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Fosfomycin PO",
                "confidence": null
              }
            },
            {
              "rank": 3,
              "drugRef": {
                "name": "trimethoprim-sulfamethoxazole",
                "variant": "PO"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Trimethoprim/sulfamethoxazole PO (TMP/SMX)",
                "confidence": null
              }
            },
            {
              "rank": 4,
              "drugRef": {
                "name": "cefpodoxime",
                "variant": "PO"
              },
              "adjuncts": null,
              "notes": [
                "Use if preferred regimens are contraindicated."
              ],
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Cefpodoxime PO",
                "confidence": null
              }
            },
            {
              "rank": 5,
              "drugRef": {
                "name": "cefazolin",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "If unable to take PO."
              ],
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Cefazolin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "nitrofurantoin",
                "variant": "PO"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Nitrofurantoin PO",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "fosfomycin",
                "variant": "PO"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Fosfomycin PO",
                "confidence": null
              }
            },
            {
              "rank": 3,
              "drugRef": {
                "name": "trimethoprim-sulfamethoxazole",
                "variant": "PO"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "TMP/SMX PO",
                "confidence": null
              }
            },
            {
              "rank": 4,
              "drugRef": {
                "name": "ciprofloxacin",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "If unable to take PO."
              ],
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Ciprofloxacin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": []
  }
}
4. Catheter-Associated UTI (from abx-05.pdf)
JSON

{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-05.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "catheter_associated_uti",
    "name": "Catheter-associated UTI",
    "setting": "hospital",
    "synonyms": [
      "CAUTI"
    ]
  },
  "diagnostics": {
    "orders": [
      "urinalysis",
      "urine_culture"
    ],
    "timing": [
      {
        "test": "urinalysis_and_culture",
        "preAntibioticPreferred": true
      }
    ],
    "deescalationRules": null
  },
  "pathways": [
    {
      "id": "no_sepsis",
      "label": "Catheter-associated UTI without sepsis and no evidence of upper tract disease",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": [
          "stable"
        ],
        "immunocompromiseGate": null
      },
      "procedureRecommendations": [
        "Remove or replace catheter prior to UA/Ucx collection & initiation of antibiotic therapy whenever feasible"
      ],
      "consult": null,
      "durationDays": {
        "min": 5,
        "max": 7,
        "from": "start",
        "notes": null,
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none",
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "observation",
                "variant": null
              },
              "adjuncts": null,
              "notes": [
                "Observation off antibiotic and await culture results."
              ],
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Observation off antibiotic and await culture results.",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "fosfomycin",
                "variant": "PO"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Fosfomycin PO",
                "confidence": null
              }
            },
            {
              "rank": 3,
              "drugRef": {
                "name": "ceftriaxone",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Ceftriaxone IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "observation",
                "variant": null
              },
              "adjuncts": null,
              "notes": [
                "Observation off antibiotic and await culture results."
              ],
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Observation off antibiotic and await culture results.",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "fosfomycin",
                "variant": "PO"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Fosfomycin PO",
                "confidence": null
              }
            },
            {
              "rank": 3,
              "drugRef": {
                "name": "ciprofloxacin",
                "variant": "IV/PO"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Ciprofloxacin IV/PO",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    },
    {
      "id": "with_sepsis",
      "label": "Catheter-associated UTI with sepsis and/or with evidence of upper tract disease",
      "firstLine": false,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": [
          "sepsis",
          "septic_shock"
        ],
        "immunocompromiseGate": null
      },
      "procedureRecommendations": [
        "Remove or replace catheter prior to UA/Ucx collection & initiation of antibiotic therapy whenever feasible"
      ],
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "For non-IgE mediated PCN reactions (SJS/DRESS) to discuss carbapenem use."
        ]
      },
      "durationDays": {
        "min": 7,
        "max": 14,
        "from": "start",
        "notes": null,
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "piperacillin-tazobactam",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Piperacillin-tazobactam IV",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV",
                "confidence": null
              }
            }
          ],
          "overrides": {
            "when": {
              "riskFlagsAny": [
                "esbl_history",
                "cephalosporin_resistant_organism_history"
              ],
              "clinicalStateIn": [
                "septic_shock"
              ]
            },
            "recommendations": [
              {
                "rank": 1,
                "drugRef": {
                  "name": "meropenem",
                  "variant": "IV"
                },
                "notes": null,
                "trace": {
                  "page": 1,
                  "sourceText": "Consider meropenem IV if:\n• History of ESBL E. coli or Klebsiella spp. or other cephalosporin resistant gram-negative organism in the last 12 months\n• Septic shock",
                  "confidence": null
                }
              }
            ]
          },
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV",
                "confidence": null
              }
            }
          ],
          "overrides": {
            "when": {
              "riskFlagsAny": [
                "esbl_history",
                "cephalosporin_resistant_organism_history"
              ],
              "clinicalStateIn": [
                "septic_shock"
              ]
            },
            "recommendations": [
              {
                "rank": 1,
                "drugRef": {
                  "name": "meropenem",
                  "variant": "IV"
                },
                "notes": null,
                "trace": {
                  "page": 1,
                  "sourceText": "Consider meropenem IV if:\n• History of ESBL E. coli or Klebsiella spp. or other cephalosporin resistant gram-negative organism in the last 12 months\n• Septic shock",
                  "confidence": null
                }
              }
            ]
          },
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "aztreonam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "If history of ESBL E. coli or Klebsiella spp. in the last 12 months or septic shock: For severe IgE mediated PCN reactions, benefit of using carbapenem should be weighed. For non-IgE mediated PCN reactions (SJS/DRESS), discuss with ID."
              ],
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Aztreonam IV PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": []
  }
}
5. Febrile UTI / Pyelonephritis (from abx-06.pdf)
JSON

{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-06.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "pyelonephritis",
    "name": "Febrile UTI / Pyelonephritis",
    "setting": "hospital",
    "synonyms": []
  },
  "diagnostics": {
    "orders": [
      "urinalysis",
      "urine_culture"
    ],
    "timing": [
      {
        "test": "urinalysis_and_culture",
        "preAntibioticPreferred": true
      }
    ],
    "deescalationRules": null
  },
  "pathways": [
    {
      "id": "community_acquired",
      "label": "Community-acquired Febrile UTI / Pyelonephritis",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": null,
        "immunocompromiseGate": null
      },
      "procedureRecommendations": null,
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if no clinical improvement past the expected duration",
          "if longer durations are clinically indicated",
          "for non-IgE mediated PCN reactions (SJS/DRESS) to discuss carbapenem use"
        ]
      },
      "durationDays": {
        "min": 7,
        "max": 7,
        "from": "start",
        "notes": "Most can be treated with 7 days if good clinical response (e.g. improvement within 3-5 days, afebrile >48 hrs).",
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none",
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "ceftriaxone",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Ceftriaxone IV",
                "confidence": null
              }
            }
          ],
          "overrides": {
            "when": {
              "riskFlagsAny": [
                "esbl_history",
                "cephalosporin_resistant_organism_history"
              ],
              "clinicalStateIn": [
                "septic_shock"
              ]
            },
            "recommendations": [
              {
                "rank": 1,
                "drugRef": {
                  "name": "ertapenem",
                  "variant": "IV"
                },
                "notes": null,
                "trace": {
                  "page": 1,
                  "sourceText": "Consider ertapenem IV If:\n• History of ESBL E. coli or Klebsiella spp. or other cephalosporin resistant gram-negative organism in the last 12 months\n• Septic shock",
                  "confidence": null
                }
              }
            ]
          },
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "aztreonam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "If history of ESBL E. coli or Klebsiella spp. in the last 12 months or septic shock: For severe IgE mediated PCN reactions, benefit of using carbapenem should be weighed. For non-IgE mediated PCN reactions (SJS/DRESS), discuss with ID."
              ],
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Aztreonam IV PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    },
    {
      "id": "hospital_acquired",
      "label": "Hospital-acquired Febrile UTI / Pyelonephritis (>48 hrs after admission)",
      "firstLine": false,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": null,
        "immunocompromiseGate": null
      },
      "procedureRecommendations": null,
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if no clinical improvement past the expected duration",
          "if longer durations are clinically indicated"
        ]
      },
      "durationDays": {
        "min": 7,
        "max": 7,
        "from": "start",
        "notes": "Most can be treated with 7 days if good clinical response (e.g. improvement within 3-5 days, afebrile >48 hrs).",
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "piperacillin-tazobactam",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Piperacillin-tazobactam IV",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV",
                "confidence": null
              }
            }
          ],
          "overrides": {
            "when": {
              "riskFlagsAny": [
                "esbl_history",
                "cephalosporin_resistant_organism_history"
              ],
              "clinicalStateIn": [
                "septic_shock"
              ]
            },
            "recommendations": [
              {
                "rank": 1,
                "drugRef": {
                  "name": "meropenem",
                  "variant": "IV"
                },
                "notes": null,
                "trace": {
                  "page": 1,
                  "sourceText": "Consider meropenem IV if:\n• History of ESBL E. coli or Klebsiella spp. or other cephalosporin resistant gram-negative organism in the last 12 months\n• Septic shock",
                  "confidence": null
                }
              }
            ]
          },
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV",
                "confidence": null
              }
            }
          ],
          "overrides": {
            "when": {
              "riskFlagsAny": [
                "esbl_history",
                "cephalosporin_resistant_organism_history"
              ],
              "clinicalStateIn": [
                "septic_shock"
              ]
            },
            "recommendations": [
              {
                "rank": 1,
                "drugRef": {
                  "name": "meropenem",
                  "variant": "IV"
                },
                "notes": null,
                "trace": {
                  "page": 1,
                  "sourceText": "Consider meropenem IV if:\n• History of ESBL E. coli or Klebsiella spp. or other cephalosporin resistant gram-negative organism in the last 12 months\n• Septic shock",
                  "confidence": null
                }
              }
            ]
          },
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": [
      {
        "type": "warn",
        "code": "MISSING_RECOMMENDATION",
        "message": "No recommendation provided for Hospital-acquired Pyelonephritis with severe PCN allergy.",
        "trace": {
          "page": 1
        }
      }
    ]
  }
}
6. Intra-abdominal Infection (from abx-07.pdf)
JSON

{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-07.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "intra_abdominal_infection",
    "name": "Intra-abdominal Infection",
    "setting": null,
    "synonyms": []
  },
  "diagnostics": null,
  "pathways": [
    {
      "id": "community_acquired",
      "label": "Community Acquired Intra-abdominal Infection",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": null,
        "immunocompromiseGate": null
      },
      "procedureRecommendations": null,
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if no clinical improvement past the expected duration",
          "in patients who are hemodynamically unstable or have difficult to achieve source control"
        ]
      },
      "durationDays": {
        "min": 4,
        "max": 4,
        "from": "source_control",
        "notes": null,
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none",
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "ceftriaxone",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV/PO"
                  }
                }
              ],
              "notes": null,
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Ceftriaxone IV (1st) PLUS Metronidazole IV/PO",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "aztreonam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV/PO"
                  }
                },
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": null,
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Aztreonam IV (1st) PLUS Metronidazole IV/PO PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    },
    {
      "id": "healthcare_associated",
      "label": "Healthcare Associated Intra-abdominal Infection",
      "firstLine": false,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": [
          "recent_iv_antibiotics_within_90_days",
          "intra_abdominal_surgery_in_last_year"
        ],
        "careLocationIn": null,
        "clinicalStateIn": null,
        "immunocompromiseGate": null
      },
      "procedureRecommendations": null,
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if no clinical improvement past the expected duration",
          "in patients who are hemodynamically unstable or have difficult to achieve source control",
          "for non-IgE mediated PCN reactions (SJS/DRESS) to discuss carbapenem use"
        ]
      },
      "durationDays": {
        "min": 4,
        "max": 4,
        "from": "source_control",
        "notes": null,
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "piperacillin-tazobactam",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "Preferred option as provides coverage for Enterococcus faecalis.",
                "ADD or Replace vancomycin with Daptomycin IV if: Severe sepsis or Septic shock, or History of VRE in the past 12 months.",
                "Consider anti-fungal therapy (i.e. micafungin) in severe sepsis or septic shock."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Piperacillin-tazobactam IV (1st)",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV/PO"
                  }
                },
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "ADD or Replace vancomycin with Daptomycin IV if: Severe sepsis or Septic shock, or History of VRE in the past 12 months.",
                "Consider anti-fungal therapy (i.e. micafungin) in severe sepsis or septic shock."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st) PLUS Metronidazole IV/PO PLUS Vancomycin IV#",
                "confidence": null
              }
            }
          ],
          "overrides": {
            "when": {
              "riskFlagsAny": [
                "esbl_history",
                "cephalosporin_resistant_organism_history"
              ],
              "clinicalStateIn": [
                "septic_shock"
              ]
            },
            "recommendations": [
              {
                "rank": 1,
                "drugRef": {
                  "name": "meropenem",
                  "variant": "IV"
                },
                "notes": null,
                "trace": {
                  "page": 1,
                  "sourceText": "Consider meropenem IV if: History of ESBL E. coli or Klebsiella spp. or other cephalosporin resistant gram-negative organism in the last 12 months or Septic shock",
                  "confidence": null
                }
              }
            ]
          },
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV/PO"
                  }
                },
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "ADD or Replace vancomycin with Daptomycin IV if: Severe sepsis or Septic shock, or History of VRE in the past 12 months.",
                "Consider anti-fungal therapy (i.e. micafungin) in severe sepsis or septic shock."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st) PLUS Metronidazole IV/PO PLUS Vancomycin IV#",
                "confidence": null
              }
            }
          ],
          "overrides": {
            "when": {
              "riskFlagsAny": [
                "esbl_history",
                "cephalosporin_resistant_organism_history"
              ],
              "clinicalStateIn": [
                "septic_shock"
              ]
            },
            "recommendations": [
              {
                "rank": 1,
                "drugRef": {
                  "name": "meropenem",
                  "variant": "IV"
                },
                "notes": null,
                "trace": {
                  "page": 1,
                  "sourceText": "Consider meropenem IV if: History of ESBL E. coli or Klebsiella spp. or other cephalosporin resistant gram-negative organism in the last 12 months or Septic shock",
                  "confidence": null
                }
              }
            ]
          },
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "aztreonam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV/PO"
                  }
                },
                {
                  "drugRef": {
                    "name": "daptomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "Vancomycin may also be used.",
                "Consider Daptomycin IV if history of VRE in past 12 months or severe sepsis or septic shock.",
                "If history of ESBL E. coli or Klebsiella spp. in the last 12 months or septic shock: For severe IgE mediated PCN reactions, benefit of using carbapenem should be weighed.",
                "Consider anti-fungal therapy (i.e. micafungin) in severe sepsis or septic shock."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Aztreonam IV (1st) PLUS Metronidazole IV/PO PLUS Daptomycin IV or Vancomycin IV#",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": []
  }
}
7. Skin and Soft Tissue Infection (Non-severe) (from abx-08.pdf)
JSON

{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-08.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "skin_soft_tissue_infection_non_severe",
    "name": "Skin and Soft Tissue Infection (Non-severe)",
    "setting": "community",
    "synonyms": [
      "SSTI",
      "cellulitis"
    ]
  },
  "diagnostics": null,
  "pathways": [
    {
      "id": "non_purulent",
      "label": "Non-purulent (non-severe) cellulitis",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": [
          "stable"
        ],
        "immunocompromiseGate": null
      },
      "procedureRecommendations": null,
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if no clinical improvement past the expected duration"
        ]
      },
      "durationDays": {
        "min": 5,
        "max": 7,
        "from": "start",
        "notes": null,
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cephalexin",
                "variant": "PO"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Cephalexin PO",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "cefazolin",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Cefazolin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefazolin",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Cefazolin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "vancomycin",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    },
    {
      "id": "purulent",
      "label": "Purulent (non-severe) cellulitis",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": [
          "stable"
        ],
        "immunocompromiseGate": null
      },
      "procedureRecommendations": null,
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if no clinical improvement past the expected duration"
        ]
      },
      "durationDays": {
        "min": 5,
        "max": 7,
        "from": "start",
        "notes": "If I&D of abscess is performed, count 5-7d from source control.",
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none",
              "pcn_mild_rash",
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "trimethoprim-sulfamethoxazole",
                "variant": "PO"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "TMP/SMX PO",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "doxycycline",
                "variant": "IV/PO"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Doxycycline IV/PO",
                "confidence": null
              }
            },
            {
              "rank": 3,
              "drugRef": {
                "name": "vancomycin",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    },
    {
      "id": "injection_related",
      "label": "Injection-related cellulitis and/or xylazine related wounds (non-severe)",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": [
          "stable"
        ],
        "immunocompromiseGate": null
      },
      "procedureRecommendations": [
        "In stable patients, hold OFF on antibiotics until wound care and thorough wound examination is performed."
      ],
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if no clinical improvement past the expected duration"
        ]
      },
      "durationDays": {
        "min": 5,
        "max": 7,
        "from": "start",
        "notes": "If I&D of abscess is performed, count 5-7d from source control.",
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "amoxicillin",
                "variant": "1gm q12h PO"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "doxycycline",
                    "variant": "IV/PO"
                  }
                }
              ],
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Amoxicillin 1gm q12h PO PLUS Doxycycline IV/PO",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "trimethoprim-sulfamethoxazole",
                "variant": "PO"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "TMP/SMX PO",
                "confidence": null
              }
            },
            {
              "rank": 3,
              "drugRef": {
                "name": "vancomycin",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Vancomycin IV",
                "confidence": null
              }
            },
            {
              "rank": 4,
              "drugRef": {
                "name": "daptomycin",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Daptomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash",
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "trimethoprim-sulfamethoxazole",
                "variant": "PO"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "TMP/SMX PO",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "vancomycin",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Vancomycin IV",
                "confidence": null
              }
            },
            {
              "rank": 3,
              "drugRef": {
                "name": "daptomycin",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Daptomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": []
  }
}
8. Severe / Necrotizing SSTI (from abx-09.pdf)
JSON

{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-09.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "skin_soft_tissue_infection_severe",
    "name": "Severe / Necrotizing SSTI",
    "setting": "hospital",
    "synonyms": [
      "NSTI"
    ]
  },
  "diagnostics": null,
  "pathways": [
    {
      "id": "severe_non_necrotizing",
      "label": "Severe sepsis patient with SSTI (non-necrotizing)",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": [
          "severe_sepsis",
          "septic_shock"
        ],
        "immunocompromiseGate": null
      },
      "procedureRecommendations": null,
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if assistance needed"
        ]
      },
      "durationDays": {
        "min": null,
        "max": null,
        "from": null,
        "notes": "Duration depends on the causative pathogen and clinical scenario. Please consult infectious diseases if assistance needed.",
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none",
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "ceftriaxone",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "Consider Cefepime IV if: immunocompromised host.",
                "For vancomycin allergy: Linezolid IV/PO OR Daptomycin IV."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Ceftriaxone IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "vancomycin",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "aztreonam",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "For vancomycin allergy: Linezolid IV/PO OR Daptomycin IV."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Vancomycin IV (1st) PLUS Aztreonam IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    },
    {
      "id": "necrotizing",
      "label": "Necrotizing SSTI (NSTI)",
      "firstLine": false,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": [
          "ICU"
        ],
        "clinicalStateIn": null,
        "immunocompromiseGate": null
      },
      "procedureRecommendations": [
        "early general surgery consultation"
      ],
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "Always recommend ID consult for NSTI",
          "For guidance on gram negative coverage in severe PCN allergy with SJS/DRESS history"
        ]
      },
      "durationDays": {
        "min": null,
        "max": null,
        "from": null,
        "notes": "Duration depends on the causative pathogen and clinical scenario. Please consult infectious diseases if assistance needed.",
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "piperacillin-tazobactam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "linezolid",
                    "variant": "IV/PO"
                  }
                }
              ],
              "notes": [
                "Linezolid has anti-toxin effects similar to clindamycin."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Piperacillin-tazobactam IV (1st) PLUS Linezolid IV/PO",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV/PO"
                  }
                },
                {
                  "drugRef": {
                    "name": "linezolid",
                    "variant": "IV/PO"
                  }
                }
              ],
              "notes": [
                "Linezolid has anti-toxin effects similar to clindamycin."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st) PLUS Metronidazole IV/PO PLUS Linezolid IV/PO",
                "confidence": null
              }
            },
            {
              "rank": 3,
              "drugRef": {
                "name": "piperacillin-tazobactam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                },
                {
                  "drugRef": {
                    "name": "clindamycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": null,
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Piperacillin-tazobactam IV (1st) PLUS Vancomycin IV PLUS Clindamycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV/PO"
                  }
                },
                {
                  "drugRef": {
                    "name": "linezolid",
                    "variant": "IV/PO"
                  }
                }
              ],
              "notes": null,
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st) PLUS Metronidazole IV/PO PLUS Linezolid IV/PO",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV/PO"
                  }
                },
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                },
                {
                  "drugRef": {
                    "name": "clindamycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": null,
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st) PLUS Metronidazole IV/PO PLUS Vancomycin IV PLUS Clindamycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "aztreonam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "linezolid",
                    "variant": "IV/PO"
                  }
                },
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV/PO"
                  }
                }
              ],
              "notes": [
                "If patient with hx of SJS/DRESS: Linezolid IV OR Vancomycin IV + Clindamycin IV AND CONSULT INFECTIOUS DISEASES for guidance on gram negative coverage"
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Aztreonam IV (1st) PLUS Linezolid IV/PO PLUS Metronidazole IV/PO",
                "confidence": null
              }
            }
          ],
          "overrides": {
            "when": {
              "riskFlagsAny": null,
              "clinicalStateIn": [
                "critically_ill"
              ]
            },
            "recommendations": [
              {
                "rank": 1,
                "drugRef": {
                  "name": "meropenem",
                  "variant": "IV"
                },
                "notes": [
                  "Consider meropenem in place of aztreonam/metronidazole if critically ill (i.e. ICU admission)"
                ],
                "trace": {
                  "page": 1,
                  "sourceText": "Consider meropenem in place of aztreonam/metronidazole if critically ill (i.e. ICU admission)",
                  "confidence": null
                }
              }
            ]
          },
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": []
  }
}
9. Diabetic Wound Infection (from abx-10.pdf)
JSON

{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-10.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "diabetic_wound_infection",
    "name": "Diabetic Wound",
    "setting": "hospital",
    "synonyms": []
  },
  "diagnostics": {
    "orders": [
      "biopsy"
    ],
    "timing": null,
    "deescalationRules": null
  },
  "pathways": [
    {
      "id": "default",
      "label": "Diabetic Wound Infection",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": null,
        "immunocompromiseGate": false
      },
      "procedureRecommendations": [
        "Patients with NO systemic signs/symptoms of infection & pending biopsy, consider monitor off antibiotic until biopsy."
      ],
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if assistance needed",
          "For SJS/DRESS history with severe PCN allergy, for guidance on gram negative coverage"
        ]
      },
      "durationDays": {
        "min": null,
        "max": null,
        "from": null,
        "notes": "Duration depends on the causative pathogen and clinical scenario. Please consult infectious diseases if assistance needed.",
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none",
              "pcn_mild_rash",
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": [
              "no_recent_antibiotic_use"
            ],
            "careLocationIn": null,
            "clinicalStateIn": [
              "mild_infection"
            ],
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "vancomycin",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "For vancomycin allergy daptomycin IV can be substituted."
              ],
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Mild, no recent antibiotic use: Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": [
              "severe_sepsis",
              "septic_shock"
            ],
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "piperacillin-tazobactam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "For vancomycin allergy daptomycin IV can be substituted."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "If Severe sepsis or septic shock:\nPiperacillin-tazobactam IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "ceftriaxone",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "For vancomycin allergy daptomycin IV can be substituted."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "All other situations without severe sepsis or septic shock\nCeftriaxone IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": [
              "severe_sepsis",
              "septic_shock"
            ],
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                },
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV/PO"
                  }
                }
              ],
              "notes": [
                "For vancomycin allergy daptomycin IV can be substituted."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "If Severe sepsis or septic shock:\nCefepime IV (1st) PLUS Vancomycin IV PLUS Metronidazole IV/PO",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "ceftriaxone",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "For vancomycin allergy daptomycin IV can be substituted."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "All other situations without severe sepsis or septic shock:\nCeftriaxone IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "vancomycin",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "aztreonam",
                    "variant": "IV"
                  }
                },
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV/PO"
                  }
                }
              ],
              "notes": [
                "If patient with hx of SJS/DRESS: Vancomycin IV (1st) AND CONSULT INFECTIOUS DISEASES for guidance on gram negative coverage.",
                "For vancomycin allergy daptomycin IV can be substituted."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "All other situations:\nVancomycin IV (1st) PLUS Aztreonam IV PLUS Metronidazole IV/PO",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": []
  }
}
10. Bite Wound (from abx-10.pdf)
JSON

{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-10.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "bite_wound",
    "name": "Bite Wound (Human, dog, cat)",
    "setting": "community",
    "synonyms": []
  },
  "diagnostics": null,
  "pathways": [
    {
      "id": "default",
      "label": "Bite Wound Infection or Prophylaxis",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": null,
        "immunocompromiseGate": null
      },
      "procedureRecommendations": [
        "Thorough wound irrigation and examination",
        "Evaluation for tetanus and/or rabies post-exposure prophylaxis",
        "Consider antibiotic prophylaxis when: Deep wounds (cat bites, Bone or Joint penetration), Wounds of face, hands or genitals, Immunocompromised, asplenia, Wound is adjacent to prosthetic material"
      ],
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "for all other bite wounds (not human, dog, cat)",
          "if assistance needed for duration"
        ]
      },
      "durationDays": {
        "min": 3,
        "max": 14,
        "from": "start",
        "notes": "Prophylaxis: 3-5 days. Mild infection: 5-7 days. Severe/complicated infection: 7-14 days.",
        "bandsBySeverity": {
          "prophylaxis": "3-5",
          "mild": "5-7",
          "severe": "7-14"
        }
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "amoxicillin-clavulanate",
                "variant": "PO"
              },
              "adjuncts": null,
              "notes": null,
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Amoxicillin-clavulanate PO",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "ampicillin-sulbactam",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "If unable to take oral agent"
              ],
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "If unable to take oral agent:\nAmpicillin-sulbactam IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "metronidazole",
                "variant": "PO"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "doxycycline",
                    "variant": "PO"
                  }
                }
              ],
              "notes": [
                "OR TMP/SMX PO OR Levofloxacin PO"
              ],
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Metronidazole PO PLUS of the following: Doxycycline PO OR TMP/SMX PO OR Levofloxacin PO",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "ceftriaxone",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "If unable to take oral agent"
              ],
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "If unable to take oral agent:\nCeftriaxone IV PLUS Metronidazole IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "metronidazole",
                "variant": "PO"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "doxycycline",
                    "variant": "PO"
                  }
                }
              ],
              "notes": [
                "OR TMP/SMX PO OR Levofloxacin PO"
              ],
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Metronidazole PO PLUS of the following: Doxycycline PO OR TMP/SMX PO OR Levofloxacin PO",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "doxycycline",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "If unable to take oral agent. Can also use Levofloxacin IV instead of Doxycycline IV."
              ],
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "If unable to take oral agent: Doxycycline IV PLUS Metronidazole IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": []
  }
}
11. Septic Arthritis (from abx-11.pdf)
JSON

{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-11.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "septic_arthritis",
    "name": "Septic arthritis",
    "setting": "hospital",
    "synonyms": []
  },
  "diagnostics": {
    "orders": [
      "synovial_fluid_gram_stain",
      "synovial_fluid_culture"
    ],
    "timing": [
      {
        "test": "synovial_fluid_gram_stain_and_cultures",
        "preAntibioticPreferred": true
      }
    ],
    "deescalationRules": [
      {
        "test": "gram_stain_and_cultures",
        "result": "positive",
        "action": "narrow",
        "target": "empiric_therapy",
        "evidence": null,
        "trace": {
          "page": 1,
          "sourceText": "Therapy should be tailored based on gram stain, culture, and sensitivities.",
          "confidence": null
        }
      }
    ]
  },
  "pathways": [
    {
      "id": "default",
      "label": "Septic Arthritis",
      "firstLine": true,
      "eligibility": null,
      "procedureRecommendations": null,
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if no clinical improvement past the expected duration",
          "if assistance needed for duration",
          "if patient has a history of organisms that are resistant to the recommended empiric regimen"
        ]
      },
      "durationDays": {
        "min": null,
        "max": null,
        "from": null,
        "notes": "Duration depends on the causative pathogen and clinical scenario. Please consult infectious diseases if assistance needed.",
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none",
              "pcn_mild_rash",
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": [
              "atraumatic_arthritis"
            ],
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "vancomycin",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "For vancomycin allergy: Linezolid IV/PO OR Daptomycin IV."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Vancomycin IV (1st)",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "none",
              "pcn_mild_rash"
            ],
            "riskFlagsAny": [
              "traumatic_arthritis",
              "pwid",
              "prosthetic_joint_infection"
            ],
            "careLocationIn": null,
            "clinicalStateIn": [
              "severe_sepsis",
              "septic_shock"
            ],
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "ceftriaxone",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": null,
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Ceftriaxone IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "none",
              "pcn_mild_rash"
            ],
            "riskFlagsAny": [
              "immunocompromised"
            ],
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": null,
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": [
              "traumatic_arthritis",
              "pwid",
              "prosthetic_joint_infection",
              "immunocompromised"
            ],
            "careLocationIn": null,
            "clinicalStateIn": [
              "severe_sepsis",
              "septic_shock"
            ],
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "aztreonam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": null,
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Aztreonam IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": []
  }
}
{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-12.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "community_acquired_meningitis",
    "name": "Community Acquired Meningitis",
    "setting": "community",
    "synonyms": []
  },
  "diagnostics": {
    "orders": [
      "lumbar_puncture"
    ],
    "timing": [
      {
        "test": "lumbar_puncture",
        "preAntibioticPreferred": false
      }
    ],
    "deescalationRules": null
  },
  "pathways": [
    {
      "id": "default",
      "label": "Community Acquired Meningitis",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": null,
        "immunocompromiseGate": null
      },
      "procedureRecommendations": [
        "Consider adding dexamethasone 0.15 mg/kg IV with the first dose administered 10-20 minutes before, or at least concomitant with, the first dose of antimicrobial therapy in adults with suspected or proven pneumococcal meningitis."
      ],
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "ID consult highly recommended for the management of meningitis",
          "if assistance needed for duration"
        ]
      },
      "durationDays": {
        "min": null,
        "max": null,
        "from": null,
        "notes": "Duration depends on the causative pathogen and clinical scenario. Please consult infectious diseases if assistance needed.",
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "ceftriaxone",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "ADD ampicillin IV for listeria if: >50 years old, History of transplant, HIV and other immunocompromised patient.",
                "For vancomycin allergy: Initiate ceftriaxone as above AND CONSULT INFECTIOUS DISEASES.",
                "Consider acyclovir IV based on clinical presentation and CSF results."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Ceftriaxone IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "ceftriaxone",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "ADD TMP/SMX IV for listeria if: >50 years old, History of transplant, HIV and other immunocompromised patient.",
                "If listeria coverage needed, and TMP/SMX contraindicated: Meropenem IV PLUS Vancomycin IV.",
                "For vancomycin allergy: Initiate ceftriaxone as above AND CONSULT INFECTIOUS DISEASES.",
                "Consider acyclovir IV based on clinical presentation and CSF results."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Ceftriaxone IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": [
              "no_sjs_dress_history"
            ],
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "meropenem",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "AND CONSULT INFECTIOUS DISEASES.",
                "ADD TMP/SMX IV for listeria if: >50 years old, History of transplant, HIV and other immunocompromised patient.",
                "For vancomycin allergy: Initiate meropenem as above AND CONSULT INFECTIOUS DISEASES.",
                "Consider acyclovir IV based on clinical presentation and CSF results."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Patients without hx of SJS/DRESS: Meropenem IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": [
              "sjs_dress_history"
            ],
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "vancomycin",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "ciprofloxacin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "ADD TMP/SMX IV for listeria if Ciprofloxacin is used AND CONSULT INFECTIOUS DISEASES.",
                "For vancomycin allergy: Initiate ciprofloxacin as above AND CONSULT INFECTIOUS DISEASES.",
                "Consider acyclovir IV based on clinical presentation and CSF results."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Patients with hx of SJS/DRESS: Vancomycin IV (1st) PLUS Ciprofloxacin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": []
  }
}
{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-13.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "healthcare_associated_meningitis",
    "name": "Healthcare associated Meningitis / Ventriculitis",
    "setting": "healthcare_associated",
    "synonyms": []
  },
  "diagnostics": null,
  "pathways": [
    {
      "id": "default",
      "label": "Healthcare associated Meningitis / Ventriculitis",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": null,
        "immunocompromiseGate": null
      },
      "procedureRecommendations": null,
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "Consult is mandatory for all treatment pathways."
        ]
      },
      "durationDays": {
        "min": null,
        "max": null,
        "from": null,
        "notes": "Duration depends on the causative pathogen and clinical scenario. Please consult infectious diseases if assistance needed.",
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none",
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "For vancomycin allergy: Initiate cefepime as above AND CONSULT INFECTIOUS DISEASES."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "aztreonam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "AND CONSULT INFECTIOUS DISEASES.",
                "For vancomycin allergy: Initiate aztreonam as above AND CONSULT INFECTIOUS DISEASES."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Aztreonam IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": []
  }
}
{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-14.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "neutropenic_fever",
    "name": "Neutropenic fever",
    "setting": "hospital",
    "synonyms": [
      "Febrile Neutropenia"
    ]
  },
  "diagnostics": null,
  "pathways": [
    {
      "id": "default",
      "label": "Absolute Neutrophil Count (ANC) of less than 500, or ANC 1000 with an expectation that the ANC will drop below 500 within 48 hours",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": null,
        "immunocompromiseGate": true
      },
      "procedureRecommendations": null,
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if assistance needed for duration",
          "for non-IgE mediated PCN reactions (SJS/DRESS) with ESBL history"
        ]
      },
      "durationDays": {
        "min": null,
        "max": null,
        "from": null,
        "notes": "Duration depends on the infectious source and ANC recovery. Please consult infectious diseases if assistance needed.",
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none",
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": [
              "septic_shock"
            ],
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "Consider Vancomycin IV if: Suspicion of PNA, SSTI, line infection; Hemodynamic instability; History of MRSA or PCN/Ceph resistant pneumococci.",
                "Consider: metronidazole IV/PO if suspected gingivitis, neutropenic enterocolitis, or perirectal abscess."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st)",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "piperacillin-tazobactam",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "Consider Vancomycin IV if: Suspicion of PNA, SSTI, line infection; Hemodynamic instability; History of MRSA or PCN/Ceph resistant pneumococci.",
                "Consider: metronidazole IV/PO if suspected gingivitis, neutropenic enterocolitis, or perirectal abscess."
              ],
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Piperacillin-tazobactam IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": {
            "drugRef": {
              "name": "tobramycin",
              "variant": "IV"
            },
            "doseNote": "5mg/kg (IBW) x 1 dose, or 2mg/kg (IBW) if HD or CrCl <20"
          }
        },
        {
          "when": {
            "allergyClassIn": [
              "none",
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "Consider Vancomycin IV if: Suspicion of PNA, SSTI, line infection; Hemodynamic instability; History of MRSA or PCN/Ceph resistant pneumococci.",
                "Consider: metronidazole IV/PO if suspected gingivitis, neutropenic enterocolitis, or perirectal abscess."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st)",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "piperacillin-tazobactam",
                "variant": "IV"
              },
              "adjuncts": null,
              "notes": [
                "Consider Vancomycin IV if: Suspicion of PNA, SSTI, line infection; Hemodynamic instability; History of MRSA or PCN/Ceph resistant pneumococci.",
                "Consider: metronidazole IV/PO if suspected gingivitis, neutropenic enterocolitis, or perirectal abscess."
              ],
              "firstAdministrationPriority": false,
              "trace": {
                "page": 1,
                "sourceText": "Piperacillin-tazobactam IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": [
              "septic_shock"
            ],
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "aztreonam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "Consider: metronidazole IV/PO if suspected gingivitis, neutropenic enterocolitis, or perirectal abscess.",
                "If history of ESBL E. coli or Klebsiella spp. in the last 12 months or septic shock: For severe IgE mediated PCN reactions, benefit of using carbapenem should be weighed. For non-IgE mediated PCN reactions (SJS/DRESS), discuss with ID."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Aztreonam IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": {
            "drugRef": {
              "name": "tobramycin",
              "variant": "IV"
            },
            "doseNote": "5mg/kg (IBW) x 1 dose, or 2mg/kg (IBW) if HD or CrCl <20"
          }
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "aztreonam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "Consider: metronidazole IV/PO if suspected gingivitis, neutropenic enterocolitis, or perirectal abscess.",
                "If history of ESBL E. coli or Klebsiella spp. in the last 12 months or septic shock: For severe IgE mediated PCN reactions, benefit of using carbapenem should be weighed. For non-IgE mediated PCN reactions (SJS/DRESS), discuss with ID."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Aztreonam IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": []
  }
}
{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-15.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "central_line_infection",
    "name": "Central Line Infection",
    "setting": "hospital",
    "synonyms": [
      "CLABSI",
      "catheter related bloodstream infection"
    ]
  },
  "diagnostics": null,
  "pathways": [
    {
      "id": "default",
      "label": "PICC lines, Ports, HD catheters",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": null,
        "immunocompromiseGate": null
      },
      "procedureRecommendations": [
        "Consider removal of lines whenever feasible"
      ],
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if no clinical improvement past the expected duration",
          "if assistance needed for duration"
        ]
      },
      "durationDays": {
        "min": null,
        "max": null,
        "from": null,
        "notes": "Duration depends on the causative pathogen and clinical scenario. Please consult infectious diseases if assistance needed.",
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "Consider Micafungin IV If the patient receives TPN via central line for >7days."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            },
            {
              "rank": 2,
              "drugRef": {
                "name": "piperacillin-tazobactam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "Consider Micafungin IV If the patient receives TPN via central line for >7days."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Piperacillin-tazobactam IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "Consider Micafungin IV If the patient receives TPN via central line for >7days."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "aztreonam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": [
                "Consider Micafungin IV If the patient receives TPN via central line for >7days."
              ],
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Aztreonam IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": []
  }
}
{
  "document": {
    "title": "Empiric Antimicrobial Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH",
    "versionDate": "2020-11",
    "fileName": "abx-15.pdf",
    "meta": {
      "notes": [
        "This document is intended as a guideline only & should NOT replace sound clinical judgement."
      ]
    }
  },
  "infection": {
    "id": "unknown_source_infection",
    "name": "Unknown Source of Infection",
    "setting": "hospital",
    "synonyms": [
      "sepsis of unknown origin"
    ]
  },
  "diagnostics": null,
  "pathways": [
    {
      "id": "default",
      "label": "Unknown source of infection",
      "firstLine": true,
      "eligibility": {
        "allergyClassIn": null,
        "riskFlagsAny": null,
        "careLocationIn": null,
        "clinicalStateIn": null,
        "immunocompromiseGate": null
      },
      "procedureRecommendations": null,
      "consult": {
        "service": "Infectious Diseases",
        "when": [
          "if no clinical improvement past the expected duration",
          "if assistance needed for duration"
        ]
      },
      "durationDays": {
        "min": null,
        "max": null,
        "from": null,
        "notes": "Duration depends on the causative pathogen and clinical scenario. Please consult infectious diseases if assistance needed.",
        "bandsBySeverity": null
      },
      "stopRules": null,
      "regimenRules": [
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": [
              "septic_shock"
            ],
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "piperacillin-tazobactam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": null,
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Piperacillin-tazobactam IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": {
            "drugRef": {
              "name": "tobramycin",
              "variant": "IV"
            },
            "doseNote": "5mg/kg (IBW) x 1 dose, or 2mg/kg (IBW) if HD or CrCl <20"
          }
        },
        {
          "when": {
            "allergyClassIn": [
              "none"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "piperacillin-tazobactam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": null,
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Piperacillin-tazobactam IV (1st) PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": [
              "septic_shock"
            ],
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV/PO"
                  }
                },
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": null,
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st) PLUS Metronidazole IV/PO PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": {
            "drugRef": {
              "name": "tobramycin",
              "variant": "IV"
            },
            "doseNote": "5mg/kg (IBW) x 1 dose, or 2mg/kg (IBW) if HD or CrCl <20"
          }
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_mild_rash"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "cefepime",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV/PO"
                  }
                },
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": null,
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Cefepime IV (1st) PLUS Metronidazole IV/PO PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": [
              "septic_shock"
            ],
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "aztreonam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV/PO"
                  }
                },
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": null,
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Aztreonam IV (1st) PLUS Metronidazole IV/PO PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": {
            "drugRef": {
              "name": "tobramycin",
              "variant": "IV"
            },
            "doseNote": "5mg/kg (IBW) x 1 dose, or 2mg/kg (IBW) if HD or CrCl <20"
          }
        },
        {
          "when": {
            "allergyClassIn": [
              "pcn_severe_anaphylaxis"
            ],
            "riskFlagsAny": null,
            "careLocationIn": null,
            "clinicalStateIn": null,
            "sourceRiskAny": null
          },
          "recommendations": [
            {
              "rank": 1,
              "drugRef": {
                "name": "aztreonam",
                "variant": "IV"
              },
              "adjuncts": [
                {
                  "drugRef": {
                    "name": "metronidazole",
                    "variant": "IV/PO"
                  }
                },
                {
                  "drugRef": {
                    "name": "vancomycin",
                    "variant": "IV"
                  }
                }
              ],
              "notes": null,
              "firstAdministrationPriority": true,
              "trace": {
                "page": 1,
                "sourceText": "Aztreonam IV (1st) PLUS Metronidazole IV/PO PLUS Vancomycin IV",
                "confidence": null
              }
            }
          ],
          "overrides": null,
          "oneTimeDose": null
        }
      ]
    }
  ],
  "validation": {
    "flags": []
  }
}